Q15116 (PDCD1_HUMAN) Homo sapiens (Human)
Programmed cell death protein 1 UniProtKBInterProSTRINGInteractive Modelling
288 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: A0A0M3M0G7
Available Structures
33 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Complex structure of PD1 and 609A-Fab |
Heteromer | 99.17 | 1×THR; 7×GOL; 7×EDO; 2×MG; 1×PEG; 1×CL; | |||
| PD-1 in complex with nivolumab Fab |
Heteromer | 99.15 | ||||
| Complex structure of PD-1 and nivolumab-Fab |
Heteromer | 100.0 | 1×NAG; | |||
| Complex structure of toripalimab-Fab and PD-1 |
Heteromer | 100.0 | 2×NAG; 1×NAG; | |||
| N-Glycosylation of PD-1 and glycosylation dependent binding of PD-1 specific monoclonal antibody ca… |
Heteromer | 100.0 | 2×NAG; 2×NAG; 3×NAG; | |||
| Crystal structure of human PD-L1 in complex with high affinity PD-1 mutant |
Heteromer Q9NZQ7; | 90.52 | 1×CL; | |||
| PD-1 in complex with Dostarlimab |
Heteromer | 99.11 | ||||
| High-resolution structure of the cemiplimab Fab in complex with PD-1 |
Heteromer | 99.08 | ||||
| High-affinity human PD-1 PD-L2 complex |
Heteromer Q9BQ51; | 93.58 | 1×MG; | |||
| Crystal structure of Fab of a PD-1 monoclonal antibody MW11-h317 in complex with PD-1 |
Heteromer | 100 | 1×NAG; 2×NAG; | |||
| The complex structure of PD-1 and cemiplimab |
Heteromer | 100.0 | ||||
| PD-1 extracellular domain in complex with Fab fragment from D12 antibody |
Heteromer | 100.0 | 1×NAG; 1×NAG; | |||
| Study of the interactions of a novel monoclonal antibody, mAb059c, with the hPD-1 receptor |
Heteromer | 99.14 | 4×EDO; | |||
| Complex structure of GY-5 Fab and PD-1 |
Heteromer | 100.0 | 1×NAG; 2×NAG; | |||
| Complex structure of GY-14 and PD-1 |
Heteromer | 100.0 | ||||
| Structural basis of HLX10 PD-1 receptor recognition, a promising anti-PD-1 antibody clinical candid… |
Heteromer | 100 | ||||
| hPD-1/NBO1a Fab complex |
Heteromer | 98.85 | ||||
| PD1 signaling receptor bound to FAB Complex |
Heteromer | 98.7 | ||||
| Structure of the complex of human programmed death-1 (PD-1) and its ligand PD-L1. |
Heteromer Q9NZQ7; | 99.06 | 1×NA; | |||
| Crystal structure of PD-1 in complex with a Fab |
Heteromer | 99.06 | ||||
| Crystal structure of PD-1 in complex with a Fab |
Heteromer | 99.06 | 1×GOL; | |||
| Complex structure of PD-1 and tislelizumab Fab |
Heteromer | 100 | 3×NAG; | |||
| PD-1 in complex with pembrolizumab Fab |
Heteromer | 99.11 | ||||
| Structure of Sasanlimab Fab in complex with PD-1 |
Heteromer | 100 | 5×GOL; | |||
| Human PD-1 ectodomain complexed with Pembrolizumab Fab |
Heteromer | 98.97 | ||||
| Crystal structure of PD-1 in complex with tislelizumab Fab |
Heteromer | 100.0 | ||||
| C-SH2 domain of SHP-2 in complex with phospho-ITSM of PD-1 |
Heteromer Q06124; | 100 | ||||
| Structure of the N-SH2 domain of the human tyrosine-protein phosphatase non-receptor type 11 in com… |
Heteromer Q06124; | 100 | ||||
| Structure of the N-SH2 domain of the human tyrosine-protein phosphatase non-receptor type 11 in com… |
Heteromer Q06124; | 100 | ||||
| Crystal structure of the extracellular domain of human PD-1 | monomer | 99.07 | ||||
| Human programmed cell death 1 receptor | monomer | 99.14 | ||||
| Human apo PD-1 triple mutant | monomer | 97.3 | 2×CL; | |||
| Human apo PD-1 double mutant | monomer | 97.39 | 2×CL; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6jjp.2.C | monomer | 0.77 | 100.00 | |||